市场调查报告书
商品编码
1513765
全球气道/肺支架市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测Global Airway/Lung Stent Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球气道/肺支架市场需求预计将从2023年的11797万美元达到2032年近22037万美元的市场规模,2024-2032年研究期间复合年增长率为7.19%。
气道/肺支架是一种医疗器械,用于使患有导致气道阻塞的患者保持气道畅通,例如肿瘤、狭窄或慢性支气管炎。这些支架由硅胶或金属等材料製成,插入气管或支气管以保持通畅并改善呼吸。气道支架可以是临时的,也可以是永久性的,有各种形状和尺寸,以适应呼吸道的不同部位。通常使用支气管镜技术放置它们。透过为气道提供结构支撑,这些支架在缓解阻塞性气道疾病患者的症状和提高生活品质方面发挥着至关重要的作用。
慢性阻塞性肺病、肺癌和气管狭窄等呼吸系统疾病的盛行率不断增加,正在推动气道/肺支架市场的成长。支架设计的技术进步,例如开发更耐用和灵活的材料,正在提高其有效性和安全性,并推动其采用。人们越来越认识到微创手术的好处以及保持气道通畅对于改善阻塞性气道疾病患者的生活品质的重要性,这也促进了市场的成长。扩大医疗基础设施和服务提供了新的市场机会,特别是在新兴经济体。旨在改善呼吸系统疾病管理的政府措施和医疗保健计划正在进一步支持市场。
人口老化更容易受到呼吸系统疾病的影响,是促进市场成长的另一个重要因素。此外,对以患者为中心的护理的日益关注和个性化治疗计划的开发推动了对气道/肺支架的需求。正在进行的研发活动专注于增强这些支架的设计和功能,预计将透过提供满足医疗保健提供者和患者不断变化的需求的创新解决方案来推动市场。然而,气道/肺支架的高成本以及支架移位和感染等併发症的可能性可能会挑战未来几年的市场成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球气道/肺支架市场的各个细分市场进行了包容性评估。气道/肺支架产业的成长和趋势为本研究提供了整体方法。
气道/肺支架市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的气道/肺支架市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。气道/肺支架市场的主要参与者包括波士顿科学公司(美国)、Taewoong Medical Co. Ltd.(韩国)、Micro-Tech(南京)有限公司(中国)、Novatech SA(法国)、Boston Medical Products Inc .(美国)、E. Benson Hood Laboratories Inc.(美国)、Merit Medical Systems Inc.(美国)、Cook Group(美国)、EFER Endoscopy(法国)、ENDO-Flex GmbH(德国)、Standard Sci 。 Tech Inc.(韩国)、Stening SRL(阿根廷)。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Airway/Lung Stent Market is presumed to reach the market size of nearly USD 220.37 Million by 2032 from USD 117.97 Million in 2023 with a CAGR of 7.19% under the study period 2024-2032.
An airway/lung stent is a medical device to keep the airways open in patients with conditions that cause airway obstruction, such as tumors, strictures, or chronic bronchitis. Made from materials like silicone or metal, these stents are inserted into the trachea or bronchi to maintain patency and improve breathing. Airway stents can be temporary or permanent and come in various shapes and sizes to fit different parts of the respiratory tract. They are typically placed using bronchoscopic techniques. By providing structural support to the airway, these stents play a crucial role in alleviating symptoms and improving the quality of life for patients with obstructive airway diseases.
The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease, lung cancer, and tracheal stenosis, is driving the growth of the airway/lung stent market. Technological advancements in stent design, such as the development of more durable and flexible materials, are enhancing their effectiveness and safety, driving their adoption. The increasing awareness of the benefits of minimally invasive procedures and the importance of maintaining airway patency in improving the quality of life for patients with obstructive airway diseases is also boosting market growth. Expanding healthcare infrastructure and services provides new market opportunities, particularly in emerging economies. Government initiatives and healthcare programs aimed at improving the management of respiratory diseases are further supporting the market.
The aging population, more susceptible to respiratory conditions, is another significant factor contributing to the market's growth. Moreover, the increasing focus on patient-centered care and the development of personalized treatment plans drive the demand for airway/lung stents. The ongoing research and development activities focused on enhancing the design and functionality of these stents are expected to drive the market by offering innovative solutions that cater to the shifting needs of healthcare providers and patients. However, the high cost of airway/lung stents and the potential for complications such as stent migration and infection may challenge market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Airway/Lung Stent. The growth and trends of Airway/Lung Stent industry provide a holistic approach to this study.
This section of the Airway/Lung Stent market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Airway/Lung Stent market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Airway/Lung Stent market include Boston Scientific Corporation (US), Taewoong Medical Co. Ltd. (South Korea), Micro-Tech (Nanjing) Co. Ltd. (China), Novatech SA (France), Boston Medical Products Inc. (US), E. Benson Hood Laboratories Inc. (US), Merit Medical Systems Inc. (US), Cook Group (US), EFER Endoscopy (France), ENDO-Flex GmbH (Germany), Standard Sci. Tech Inc. (South Korea), Stening SRL (Argentina). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.